Background: Colorectal cancer (CRC) is a leading cause of cancer incidence and mortality. Screening can result in reductions in incidence and mortality, but there are many challenges to uptake and follow-up.
Content: Here, we will review the changing epidemiology of CRC, including increasing trends for early and later onset CRC; evidence to support current and emerging screening strategies, including noninvasive stool and blood-based tests; key challenges to ensuring uptake and high-quality screening; and the critical role that clinical laboratories can have in supporting health system and public health efforts to reduce the burden of CRC on the population.
Summary: Clinical laboratories have the opportunity to play a seminal role in optimizing early detection and prevention of CRC.
Published by Oxford University Press on behalf of Association for Diagnostics & Laboratory Medicine 2024.